Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS
· Delayed Price · Currency is USD
0.0360
-0.0040 (-10.00%)
Apr 28, 2026, 1:54 PM EST
Oncotelic Therapeutics Employees
Oncotelic Therapeutics had 26 employees as of December 31, 2024. The number of employees increased by 4 or 18.18% compared to the previous year.
Employees
26
Change (1Y)
4
Growth (1Y)
18.18%
Revenue / Employee
n/a
Profits / Employee
$6,079,996
Market Cap
15.99M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Zeo ScientifiX | 20 |
| Inhibitor Therapeutics | 8 |
| Anebulo Pharmaceuticals | 3 |
| HOOKIPA Pharma | 87 |
| Provectus Biopharmaceuticals | 6 |
| Harvard Apparatus Regenerative Technology | 8 |
| Brainstorm Cell Therapeutics | 20 |
Oncotelic Therapeutics News
- 4 days ago - NetworkNews Audio Announces Audio Press Release (APR) Discussing Advancing Oncology Therapeutics, Strategic Positioning within High-Value Development Pathways - GlobeNewsWire
- 4 days ago - Oncotelic Therapeutics Provides Corporate Update on Partnership Strategy - GlobeNewsWire
- 5 days ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation - GlobeNewsWire
- 7 days ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) Leveraging Expertise amid Evaluation Evolution - GlobeNewsWire
- 12 days ago - Oncotelic Therapeutics Reports FY 2025 Results Highlighting $249M Net Income and JV Pipeline Progress - GlobeNewsWire
- 18 days ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) Strengthening Position with AI-Driven Tech in Automated Compliance Space - GlobeNewsWire
- 20 days ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) Operates at Intersection of Life Sciences, Advanced Digital Technologies, - GlobeNewsWire
- 5 weeks ago - Sapu Nano to Launch Deciparticle™ Platform and Present Clinical Pipeline at BIO-Europe Spring 2026 - GlobeNewsWire